Who We Are

The Alliance for Longevity Initiatives (A4LI) proudly stands as the inaugural 501(c)(4) nonprofit organization specifically created to ignite social and political action focused on mitigating age-related diseases and fostering an increase in our healthy, active years. Visionary founder Dylan Livingston, leveraging his rich background as a grassroots political organizer, launched A4LI in 2022 in response to the burgeoning call for legislative advocacy within the rapidly evolving longevity sector.

A4LI’s inception comes at a pivotal moment when breakthroughs in science and surges in funding have primed the industry for transformation. With an eye on the future, we endeavor to align with healthcare pioneers and thought leaders within the realms of geroscience and policy-making. Our mission is to ensure that the initiatives we advance are strategic and impactful, designed to realize A4LI’s commitment to extending the healthspan of society.

A4LI was the driving force behind:

Forming the Longevity Science Caucus: Formed February 2023, the Caucus aims to educate policymakers about geroscience and its positive effects on society. The Caucus will be crucial for increasing federal funding for aging biology and refining FDA regulations for aging therapeutics.

Passage of SB 422; Expanding Right to Try Access in Montana: Effective October 1, 2023, all patients in Montana gained the right to access investigational drugs that have passed Phase I clinical trials but have not yet been approved for general use by the FDA.